Abivax S.A. Operating Expense
Abivax S.A. (ABVX) reported Operating Expense of EUR 250.63 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:OperatingExpense · last filed 2026-03-23
- Abivax S.A. operating expense for the quarter ending 2025-12-31 was 72.09M EUR, a 53.03% increase year-over-year.
- Abivax S.A. operating expense for the quarter ending 2025-09-30 was 82.75M EUR, a 60.65% increase year-over-year.
- Abivax S.A. operating expense for the quarter ending 2025-06-30 was 47.59M EUR, a 16.20% increase year-over-year.
- Abivax S.A. operating expense for the quarter ending 2025-03-31 was 48.19M EUR, a 5.10% increase year-over-year.
| Period end | Operating Expense 3 month | Operating Expense 6 month | Operating Expense 9 month | Operating Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | 72.09M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-23 | 154.84M EUR derived: sum of 2 quarters · filed 2026-03-23 | 202.43M EUR derived: sum of 3 quarters · filed 2026-03-23 | 250.63M EUR 20-F · filed 2026-03-23 |
| 2025-09-30 | 82.75M EUR 6-K · filed 2025-12-15 | 130.34M EUR derived: sum of 2 quarters · filed 2025-12-15 | 178.54M EUR 6-K · filed 2025-12-15 | 225.65M EUR derived: sum of 4 quarters · filed 2026-03-23 |
| 2025-06-30 | 47.59M EUR 6-K · filed 2025-09-08 | 95.78M EUR 6-K · filed 2025-09-08 | 142.89M EUR derived: sum of 3 quarters · filed 2026-03-23 | 194.41M EUR derived: sum of 4 quarters · filed 2026-03-23 |
| 2025-03-31 | 48.19M EUR 6-K · filed 2025-06-02 | 95.30M EUR derived: sum of 2 quarters · filed 2026-03-23 | 146.82M EUR derived: sum of 3 quarters · filed 2026-03-23 | 187.77M EUR derived: sum of 4 quarters · filed 2026-03-23 |
| 2024-12-31 | 47.11M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-23 | 98.62M EUR derived: sum of 2 quarters · filed 2026-03-23 | 139.58M EUR derived: sum of 3 quarters · filed 2026-03-23 | 185.43M EUR 20-F · filed 2026-03-23 |
| 2024-09-30 | 51.51M EUR 6-K · filed 2025-12-15 | 92.47M EUR derived: sum of 2 quarters · filed 2025-12-15 | 138.32M EUR 6-K · filed 2025-12-15 | |
| 2024-06-30 | 40.95M EUR 6-K · filed 2025-09-08 | 86.81M EUR 6-K · filed 2025-09-08 | ||
| 2024-03-31 | 45.86M EUR 6-K · filed 2025-06-02 | |||
| 2023-12-31 | 132.00M EUR 20-F · filed 2026-03-23 | |||
| 2022-12-31 | 69.42M EUR 20-F · filed 2025-03-24 | |||
| 2021-12-31 | 53.36M EUR 20-F · filed 2024-04-05 |